Quick Answer
VitaNova Life Sciences Corp reported Cash And Cash Equivalents At Carrying Value of $8.7 thousand for the year ending 2023.
- VitaNova Life Sciences Corp showed a decrease of -62.2% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
- This data is from VitaNova Life Sciences Corp's annual report (Form 10-K), filed with the SEC on May 15, 2023.
- XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $13.4 thousand | Q1 2018: $487.00 | Q3 2018: $602.00 | Q4 2018: $0.00 | Q1 2019: $50.00 | Q3 2019: $0.00 | Q4 2019: $0.00 | Q1 2020: $0.00 | Q2 2020: $0.00 | Q3 2020: $0.00 | Q4 2020: $0.00 | Q1 2021: $0.00 | Q3 2021: $0.00 | Q4 2021: $31.7 thousand | Q1 2022: $36.9 thousand | Q3 2022: $29.9 thousand | Q4 2022: $35.2 thousand | Q1 2023: $11.0 thousand | Q2 2023: $8.7 thousand | Q3 2023: $0.00 | Q1 2024: $808.4 thousand.
- Over the full 7 years of available data (2017 to 2023), VitaNova Life Sciences Corp's Cash And Cash Equivalents At Carrying Value has grown by 4,157.6%.
- Historical annual values: Fiscal year 2023: $8.7 thousand | Fiscal year 2022: $23.1 thousand | Fiscal year 2021: $0.00 | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $4.4 thousand | Fiscal year 2017: $205.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: